Cisplatin cas number
WebSynonym (s): cis-Diammineplatinum (II) dichloride, cis-Dichlorodiammine platinum (II), cis-Platinum (II) diammine dichloride, Cisplatin Linear Formula: Pt (NH3)2Cl2 CAS Number: 15663-27-1 Molecular Weight: 300.05 Numero CE: 239-733-8 Numero MDL: MFCD00011623 ID PubChem: 329774978 NACRES: NA.24 Request a Bulk Order Add … Cisplatin is a chemotherapy medication used to treat a number of cancers. These include testicular cancer, ovarian cancer, cervical cancer, bladder cancer, head and neck cancer, esophageal cancer, lung cancer, mesothelioma, brain tumors and neuroblastoma. It is given by injection into a vein. Common side effects include bone marrow suppression, hearing problems, incl…
Cisplatin cas number
Did you know?
Webcis-Diammineplatinum(II) dichloride, cis-Dichlorodiammine platinum(II), cis-Platinum(II) diammine dichloride, Cisplatin Linear Formula: Pt(NH3)2Cl2 CAS Number: 15663-27-1 Molecular Weight: 300.05 EC Number: 239-733-8 MDL number: MFCD00011623 PubChem Substance ID: 24871609 NACRES: NA.22 Recommended Products Slide 1 of … WebCisplatin is a potent anticancer agent that blocks DNA synthesis. Induces apoptosis via p53-dependent and -independent mechanisms. Inhibits X-linked inhibitor of apoptosis protein (XIAP) expression and activates caspase-3. In certain glioma cell lines, sensitizes cells to TNF- α -induced apoptosis. Technical Data for Cisplatin
WebOct 4, 2024 · Cisplatin CAS Registry Number 15663-27-1 Drug Class Breast Feeding Lactation Milk, Human Antineoplastic Agents Platinum Compounds Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your … Web· Trade name:Cisplatin · Article number:13119 · CAS Number: 15663-27-1 · EC number: 239-733-8 · Application of the substance / the mixture This product is for research use - …
WebCisplatin Pharmaceutical Secondary Standard; Certified Reference Material Synonym (s): cis-Diammineplatinum (II) dichloride, cis-Dichlorodiammine platinum (II), cis-Platinum (II) diammine dichloride, Cisplatin Linear Formula: Pt (NH3)2Cl2 CAS Number: 15663-27-1 Molecular Weight: 300.05 EC Number: 239-733-8 MDL number: MFCD00011623 WebIn a number of studies, cisplatin-induced platinum-DNA adducts were observed in tissue culture (IARC 1987b) and in patients receiv-ing cisplatin-based chemotherapy (Reed et al. 1993). Properties Cisplatin is a metallic (platinum) coordination compound with a square planar geometry that is a white or deep yellow to yellow-
WebCAS Number: 15663-27-1. Molecular Weight: 300.05. EC Number: 239-733-8. MDL number: MFCD00011623. PubChem Substance ID: 329774978. NACRES: NA.24. ... Cisplatin - CAS 15663-27-1, is a platinum coordination complex with potent anti-neoplastic activity. Induces apoptosis in cancer cells, possibly via caspase-3 activation. ...
WebCisplatin - CAS 15663-27-1, is a platinum coordination complex with potent anti-neoplastic activity. Induces apoptosis in cancer cells, possibly via caspase-3 activation. Cisplatin - CAS 15663-27-1 - Calbiochem MSDS (material safety data sheet) or SDS, CoA and CoQ, dossiers, brochures and other available documents. SDS CoA References Data Sheet raymond wareham rockefellerWebCisplatin Cisplatin Systematic (IUPAC) name cis-diamminedichloridoplatinum(II) Identifiers CAS number 15663-27-1 ATC code L01XA01 PubChem 84691 DrugBank. ... CAS number: 15663-27-1: ATC code: L01 XA01: PubChem: 84691: DrugBank: APRD00359: Chemical data: Formula: H 6 Cl 2 N 2 Pt : Mol. mass: 300.05 g/mol Pharmacokinetic … simplifying expressions testWebCisplatin CAS No. 15663-27-1 Reasonably anticipated to be a human carcinogen First listed in the Fifth Annual Report on Carcinogens (1989) Also known as cis … raymond warner cookie glovesWebIngredient CAS Number EU EINECS/ELINCS List EU Classification % Sodium chloride 7647-14-5 231-598-3 Not Listed * Mannitol 69-65-8 200-711-8 Not Listed * Additional Information: * Proprietary ... Material Name: Cisplatin Freeze-Dried Powder for Injection Version: 2.0 Page 2 of 8. simplifying expressions using exponent lawsWebConclusion: TGF-β induced TMEPAI contributes to the reduced response of TNBC treatment to doxorubicin and paclitaxel, but minimal on cisplatin and bicalutamide. Further study is needed to confirm our findings in other growth factor-induced cells, as well as in in vivo model. Keywords: TMEPAI, TGF-β, doxorubicin, paclitaxel. simplifying expressions to lowest termsWebJul 15, 2024 · 1.1 GHS Product identifier Product name cisplatin 1.2 Other means of identification 1.3 Recommended use of the chemical and restrictions on use 1.4 Supplier's details 1.5 Emergency phone number SECTION 2: Hazard identification 2.1 Classification of the substance or mixture Acute toxicity - Category 2, Oral Serious eye damage, … raymond warner.com uk shopWebCisplatin United States Pharmacopeia (USP) Reference Standard Synonym (s): cis-Diammineplatinum (II) dichloride, cis-Dichlorodiammine platinum (II), cis-Platinum (II) … raymond warner gloves australia